National Drug Intelligence Center; Agency Information Collection Activities: Proposed Reinstatement With Change of a Previously Approved Collection; Comments Requested, 56552 [06-8210]

Download as PDF 56552 Federal Register / Vol. 71, No. 187 / Wednesday, September 27, 2006 / Notices Management and Security Staff, Justice Management Division, United States Department of Justice, Suite 1600, 601 D Street, NW., Washington, DC 20530. Dated: September 20, 2006. Lynn Bryant, Department Clearance Officer, United States Department of Justice. [FR Doc. 06–8209 Filed 9–26–06; 8:45 am] BILLING CODE 4410–07–P DEPARTMENT OF JUSTICE Overview of This Information Collection [OMB Number 1105–0071] National Drug Intelligence Center; Agency Information Collection Activities: Proposed Reinstatement With Change of a Previously Approved Collection; Comments Requested 60-Day Notice of Information Collection Under Review: Reinstatement with change of a previously approved collection National Drug Threat Survey. rwilkins on PROD1PC63 with NOTICES ACTION: The United States Department of Justice (DOJ), National Drug Intelligence Center (NDIC), has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. Comments are encouraged and will be accepted for sixty days until November 27, 2006. This process is conducted in accordance with 5 CFR 1320.10. If you have comments especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Kevin M. Walker, Chief Counsel, National Drug Intelligence Center, Fifth Floor, 319 Washington Street, Johnstown, PA 15901. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; VerDate Aug<31>2005 16:48 Sep 26, 2006 —Enhance the quality, utility, and clarity of the information to be collected; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Jkt 208001 (1) Type of Information Collection: Extension Reinstatement with Change of a Previously Approved Collection. (2) Title of the Form/Collection: National Drug Threat Survey. (3) Agency form number, if any, and the applicable component of the Department of Justice sponsoring the collection: Form Number: NDIC Form # A–34g. (4) Affected public who will be asked or required to respond, as well as a brief abstract: Primary: Federal, State, and local, law enforcement agencies. This survey is a critical component of the National Drug Threat Assessment and other reports and assessments produced by the National Drug Intelligence Center. It provides direct access to detailed drug threat data from state and local law enforcement agencies. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: It is estimated that approximately 3,500 respondents will complete a survey response within approximately 20 minutes. (6) An estimate of the total public burden (in hours) associated with the collection: There are an estimated 1,167 total annual burden hours associated with this collection. Ms. Lynn Bryant, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Patrick Henry Building, Suite 1600, 601 D Street, NW., Washington, DC 20530. FOR FURTHER INFORMATION CONTACT: Dated: September 20, 2006. Lynn Bryant, Department Clearance Officer, Department of Justice. [FR Doc. 06–8210 Filed 9–26–06; 8:45 am] BILLING CODE 4410–DC–P PO 00000 Frm 00085 Fmt 4703 Sfmt 4703 DEPARTMENT OF JUSTICE Notice of Lodging of Consent Decree Under the Clean Water Act Notice is hereby given that on September 15, 2006, a proposed consent decree in United States v. C&D Technologies, Inc., Civ. No. 1:03–cv–413 was lodged with the United States District Court for the Southern District of Indiana. In this action the United States sought civil penalties and injunctive relief for alleged violations of the Clean Water Act and its pertinent regulations at C&D Technologies, Inc.’s lead acid battery manufacturing facility in Attica, Indiana. Specifically, the United States’ complaint alleged: (1) Violations of the Pretreatment Standards for Existing Sources and new sources of pollution (‘‘PSES’’), 40 CFR 403, and the PSES for Battery Manufacturing, 40 CFR 403.5(d) and CWA Section 307(d), 33 U.S.C. 1317(d); (2) violations of C&D’s National Pollution Discharge Elimination System permit (‘‘NPDES Permit’’) and CWA Sections 301 and 402, 33 U.S.C. 1311 and 1342; (3) that C&D through the presence of lead in its effluent prevented the Attica, Indiana, Publicly Owned Treatment Works (‘‘POTW’’) from using the POTW’s chosen sludge use or disposal practice, in violation of 40 CFR 403.5 and 403.2, and CWA Section 307(d) 33 USC 1317(d); (4) that C&D failing to submit compliance reports in violation of 40 CFR 403.12 and DWA Section 307, 33 U.S.C. 1317; (5) that C&D failed to comply with the PSES for Battery Manufacturing by failing to monitor its effluent for copper content, in violation of 40 CFR 461.34, 40 CFR 403.12(g), and CWA Section 307, 33 U.S.C. 1317 and (6) that C&D failed to comply with certain provisions of a 1997 Administrative Order, in violation of CWA Sections 308 and 309, 33 U.S.C. 1318 and 1319. Under the proposed Consent Decree, C&D would pay a civil penalty of $1,600,000 and undertake various injunctive relief measures in addition to previous injunctive relief expenditures. The Department of Justice will receive for a period of thirty (30) days from the date of this publication comments relating to the proposed Consent Decree. Comments should be addressed to the Assistant Attorney General, Environment and Natural Resources Division, P.O. Box 7611, U.S. Department of Justice, Washington, DC 20044–7611, and should refer to United States v. C&D Technologies, Inc., D.J. Ref. 90–5–1–1–06996. The proposed Consent Decree may be examined at the Office of the United E:\FR\FM\27SEN1.SGM 27SEN1

Agencies

Department of Justice

[Federal Register Volume 71, Number 187 (Wednesday, September 27, 2006)]
[Notices]
[Page 56552]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-8210]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

[OMB Number 1105-0071]


National Drug Intelligence Center; Agency Information Collection 
Activities: Proposed Reinstatement With Change of a Previously Approved 
Collection; Comments Requested

ACTION: 60-Day Notice of Information Collection Under Review: 
Reinstatement with change of a previously approved collection National 
Drug Threat Survey.

-----------------------------------------------------------------------

    The United States Department of Justice (DOJ), National Drug 
Intelligence Center (NDIC), has submitted the following information 
collection request to the Office of Management and Budget (OMB) for 
review and approval in accordance with the Paperwork Reduction Act of 
1995. The proposed information collection is published to obtain 
comments from the public and affected agencies. Comments are encouraged 
and will be accepted for sixty days until November 27, 2006. This 
process is conducted in accordance with 5 CFR 1320.10.
    If you have comments especially on the estimated public burden or 
associated response time, suggestions, or need a copy of the proposed 
information collection instrument with instructions or additional 
information, please contact Kevin M. Walker, Chief Counsel, National 
Drug Intelligence Center, Fifth Floor, 319 Washington Street, 
Johnstown, PA 15901.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address one or more of the following 
four points:

--Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility;
--Evaluate the accuracy of the agencies estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used;
--Enhance the quality, utility, and clarity of the information to be 
collected; and
--Minimize the burden of the collection of information on those who are 
to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submission of responses.

Overview of This Information Collection

    (1) Type of Information Collection: Extension Reinstatement with 
Change of a Previously Approved Collection.
    (2) Title of the Form/Collection: National Drug Threat Survey.
    (3) Agency form number, if any, and the applicable component of the 
Department of Justice sponsoring the collection: Form Number: NDIC Form 
 A-34g.
    (4) Affected public who will be asked or required to respond, as 
well as a brief abstract: Primary: Federal, State, and local, law 
enforcement agencies. This survey is a critical component of the 
National Drug Threat Assessment and other reports and assessments 
produced by the National Drug Intelligence Center. It provides direct 
access to detailed drug threat data from state and local law 
enforcement agencies.
    (5) An estimate of the total number of respondents and the amount 
of time estimated for an average respondent to respond: It is estimated 
that approximately 3,500 respondents will complete a survey response 
within approximately 20 minutes.
    (6) An estimate of the total public burden (in hours) associated 
with the collection: There are an estimated 1,167 total annual burden 
hours associated with this collection.

FOR FURTHER INFORMATION CONTACT: Ms. Lynn Bryant, Department Clearance 
Officer, United States Department of Justice, Justice Management 
Division, Policy and Planning Staff, Patrick Henry Building, Suite 
1600, 601 D Street, NW., Washington, DC 20530.

    Dated: September 20, 2006.
Lynn Bryant,
Department Clearance Officer, Department of Justice.
[FR Doc. 06-8210 Filed 9-26-06; 8:45 am]
BILLING CODE 4410-DC-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.